Taking a prescription medication? See what real patients say about timing, side effects & cash prices. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data

Medications Starting With "B" (74)

Interactive 24-Hour Pill, Supplement & Coffee Clock • FDA DailyMed Spacing + CMS NADAC Cash Price Check

“Can I Take These Together?” Build Your Conflict-Free Daily Schedule

Toggle your prescriptions and supplements below to see stomach mineral absorption blocks, CYP450 conflicts, and your exact 24-hour clock:

1. Select Your Daily Prescriptions & Supplements (Click to Toggle):
⚠ Active Chelation & Co-Factor Audit (FDA DailyMed + NIH RxNorm)
6 Active Items Scheduled Across 4 Conflict-Free Windows
  • 4-Hour Chelation Block (Levothyroxine + Magnesium / Iron): Magnesium and Iron bind to Levothyroxine in the stomach, cutting thyroid absorption by 30%–45%. We automatically moved Iron to 10:30 AM and Magnesium to 9:30 PM.
  • 60-Minute Coffee & Espresso Rule: Brewed coffee sequesters oral T4 tablets inside the intestinal lumen. Wait 45–60 minutes after 6:30 AM Levothyroxine before drinking coffee (or ask about Tirosint gelcaps).
  • Metformin ER + Vitamin B12 Depletion: Long-term Metformin impairs calcium-dependent ileal B12 uptake. Take Metformin ER mid-dinner (6:30 PM) and verify Serum B12 + MMA annually.
  • Atorvastatin / Rosuvastatin + CoQ10 Synergy: Statins inhibit mevalonate synthesis, lowering endogenous CoQ10. Pairing 100–200 mg Ubiquinol with lunch/dinner supports muscle ATP.
6:30 AM • Fasting Water Only
Levothyroxine (Synthroid / Euthyrox)

Take 30–60 min before coffee/breakfast; keep 4 hours away from Iron, Calcium & Magnesium.

Iron Bisglycinate (25–28 mg Elemental)

Alternate-day morning dosing with 200 mg Vitamin C avoids the 24h hepcidin block and protects Levothyroxine.

12:30 PM • Lunch With 15g Fat
Vitamin D3 (2,000–5,000 IU) + MK-7 + CoQ10

Fat-soluble D3, K2 (MK-7), Omega-3 rTG, and CoQ10 Ubiquinol absorb 32%–50% better with dietary fat.

6:30 PM • Mid-Dinner GI Buffer
Metformin ER (500–1,000 mg)

Taking Extended-Release (ER) mid-dinner cuts GI nausea/diarrhea by >60%. Check Vitamin B12 + MMA yearly.

Atorvastatin (20 mg) or Rosuvastatin (10 mg)

Pairs cleanly with dinner alongside CoQ10 Ubiquinol (100–200 mg) to support muscle mitochondrial ATP.

9:30 PM • Bedtime 60m Pre-Sleep
Magnesium Bisglycinate (200–300 mg Elemental)

Safely separated 15 hours from morning Levothyroxine; glycine + Mg2+ support GABAergic deep sleep.

Verified 30-Day Generic Cash Price Check (Cost Plus & CMS NADAC Benchmark)

Never pay a $45–$68 retail pharmacy walk-in markup for pennies-per-pill generics:

Alphabetical Index • Letter "B"

Medications Starting With "B" (74)

Clear Filter × Page 2 of 3
Androgen Receptor Inhibitor

Bicalutamide

Brands: Casodex

Targets androgen receptor inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $12.63 Generic Cash • $11.83 NADAC • RxCUI 199123
FDA Prescription Monograph

Bicisate Dihydrochloride

Brands: Neurolite

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$50.40/mo NADAC • $188 Retail Avg
Prostaglandin Analog

Bimatoprost

Brands: Lumigan • Latisse • Durysta

Targets prostaglandin analog pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $15.06 Generic Cash • $114.75 NADAC • RxCUI 308739
FDA Prescription Monograph

Bimekizumab

Brands: Bimzelx

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg • RxCUI 2668086
FDA Prescription Monograph

Binimetinib

Brands: Mektovi

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$84.00/mo NADAC • $299 Retail Avg • RxCUI 2049127
Stimulant Laxative

Bisacodyl

Brands: Laxative • Onelax • Gentle Laxative

Targets stimulant laxative pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$10.76/mo NADAC • $56 Retail Avg • RxCUI 308753
Stimulant Laxative

Bisacodyl 5mg

Brands: Laxative Enteric Coated • Laxative • Laxomil

Targets stimulant laxative pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$10.76/mo NADAC • $56 Retail Avg
Bismuth

Bismuth Subsalicylate

Brands: Stomach Relief, Ultra Strength • First Aid Direct Peptum Tabs • Max Strength Stomach Relief

Targets bismuth pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$0.37/mo NADAC • $35 Retail Avg • RxCUI 308763
beta-Adrenergic Blocker

Bisoprolol Fumarate

Brands: Zebeta

Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.

Price & Supply: $6.76 Generic Cash • $4.71 NADAC • RxCUI 854901
Anti-coagulant

Targets anti-coagulant pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$83.40/mo NADAC • $297 Retail Avg • RxCUI 308769
Cytoprotective Agent

Targets cytoprotective agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$672/mo NADAC • $453 Retail Avg • RxCUI 1726673
Amide Local Anesthetic

Blood Clotter

Brands: Super-Stop Bloodclotter

Targets amide local anesthetic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$17.40/mo NADAC • $78 Retail Avg • RxCUI 1545716
Proteasome Inhibitor

Bortezomib

Brands: Boruzu • Velcade

Targets proteasome inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$81.00/mo NADAC • $289 Retail Avg • RxCUI 402243
Endothelin Receptor Antagonist

Bosentan

Brands: Tracleer

Targets endothelin receptor antagonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$44.10/mo NADAC • $167 Retail Avg • RxCUI 349253
Kinase Inhibitor

Bosutinib

Brands: Bosulif

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$75.60/mo NADAC • RxCUI 1987732
Acetylcholine Release Inhibitor

Botulinum Toxin Type A

Brands: Daxxify • Dysport

Targets acetylcholine release inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$18.60/mo NADAC • $82 Retail Avg • RxCUI 2612454
CD30-directed Immunoconjugate

Brentuximab Vedotin

Brands: Adcetris

Targets cd30-directed immunoconjugate pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$49.80/mo NADAC • $186 Retail Avg • RxCUI 1147323
Disclosing Agent

Brilliant Blue G

Brands: Tissueblue

Targets disclosing agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$72.30/mo NADAC • $260 Retail Avg
alpha-Adrenergic Agonist

Brimonidine

Brands: Alphagan P

Targets alpha-adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $9.60 Generic Cash • $410.12 NADAC • RxCUI 1437707
FDA Prescription Monograph

Brincidofovir

Brands: Tembexa

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$28.20/mo NADAC • $114 Retail Avg • RxCUI 2599525
Carbonic Anhydrase Inhibitor

Brinzolamide

Brands: Azopt

Targets carbonic anhydrase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $62.50 Generic Cash • $99.53 NADAC • RxCUI 213272
Epoxide Hydrolase Inhibitors [MoA]

Brivaracetam

Brands: Briviact

Targets epoxide hydrolase inhibitors [moa] pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$7.47/mo NADAC • $46 Retail Avg • RxCUI 1739749
Interleukin-17 Receptor A Antagonist

Brodalumab

Brands: Siliq

Targets interleukin-17 receptor a antagonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$60.60/mo NADAC • $221 Retail Avg • RxCUI 1872256
Nonsteroidal Anti-inflammatory Drug

Bromfenac Sodium

Brands: Bromfenac Ophthalmic Solution • Prolensa • Bromfenac Ophthalmic Solution, 0.07%

Attenuates inflammatory prostaglandin synthesis, neuropathic firing, or crystal arthropathy pain.

Price & Supply: $23.25 Generic Cash • $353.02 NADAC • RxCUI 1375917
Ergot Derivative

Bromocriptine Mesylate

Brands: Cycloset • Parlodel

Targets ergot derivative pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $35.19 Generic Cash • $120.59 NADAC • RxCUI 197411
Corticosteroid

Budesonide

Brands: Pulmicort Flexhaler • Tarpeyo • Pulmicort

Targets corticosteroid pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $25.06 Generic Cash • $19.89 NADAC • RxCUI 349094
Loop Diuretic

Bumetanide

Brands: Bumex • Enbumyst

Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.

Price & Supply: $6.39 Generic Cash • $3.75 NADAC • RxCUI 197419
Amide Local Anesthetic

Bupivacaine

Brands: Exparel

Targets amide local anesthetic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$1.37/mo NADAC • $35 Retail Avg • RxCUI 1191508
Amide Local Anesthetic

Targets amide local anesthetic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$91.80/mo NADAC • $324 Retail Avg
Amide Local Anesthetic

Targets amide local anesthetic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$5.40/mo NADAC • $39 Retail Avg
Partial Opioid Agonist

Buprenorphine

Brands: Sublocade • Butrans • Brixadi

Targets partial opioid agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$583/mo NADAC • $453 Retail Avg • RxCUI 904870
Partial Opioid Agonist

Targets partial opioid agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$912/mo NADAC • $453 Retail Avg
Aminoketone

Bupropion Hydrochloride SR

Brands: Wellbutrin SR

Targets aminoketone pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.83 Generic Cash • $3.58 NADAC • RxCUI 993503
Mental Health Agent

Buspirone Hydrochloride

Brands: Buspirone HCl • Bucapsol • Buspar

Targets mental health agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.24 Generic Cash • $0.65 NADAC • RxCUI 866018
Connected Clinical Ecosystem • Conditions, Supplements & Specialists

Pair Your Prescription Guide With Diagnostic Cutoffs & Nutrient Depletion Rules

Medical Conditions (/conditions)

Diagnostic Lab Cutoffs & First-Line Protocols

See exact ACC/AHA blood pressure stages, ADA HbA1c thresholds, and step-up treatment ladders across 40 specialty hubs.

Dietary Supplements (/supplements)

Drug-Induced Nutrient Depletions & Label Math

Check when statins, Metformin, or PPIs deplete CoQ10, Vitamin B12, or Magnesium—and how to decode elemental supplement labels.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Find board-certified endocrinologists, cardiologists, and internists verified by CMS Medicare Part B volume and accepted insurance plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "B" (74)?

dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.

Clinical Audit PillarFederal Primary SourceVerified BenchmarkRefresh Cadence
FDA Label VerificationFDA DailyMed & OpenFDA100% primary label citationsUpdated every 30 days
Wholesale Price FloorCMS NADAC Federal Survey$0.45–$2.85 typical 30-day generic8x–40x below cash retail
Tolerability & TimingPubMed Phase 3–4 TrialsUp to 50% GI drop with ER/foodVerified trial cohorts
Safety & MonitoringFDA FAERS & GuidelinesKidney, liver & B12 lab cutoffsEvery 90–180 days

What safety and cost checks should patients review before filling Medications Starting With "B" (74)?

dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee